Risk factors for invasive fusariosis in patients with acute myeloid leukemia and in hematopoietic cell transplant recipients

Clinical Infectious Diseases

Volumn 60, Issue 6, 2015, Pages 875-880

  Garnica, Marcia ^a   Da Cunha, Marcos Oliveira ^b   Portugal, Rodrigo ^a   Maiolino, Angelo ^a   Colombo, Arnaldo L ^c   Nucci, Marcio ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Hospital Naval Marcilio Dias   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute leukemia; Bone marrow transplant; Invasive fungal disease; Invasive fusariosis; Risk factor

Indexed keywords

CORTICOSTEROID; CYTARABINE; IDARUBICIN; POSACONAZOLE; THYMOCYTE ANTIBODY; VORICONAZOLE; LYMPHOCYTE ANTIBODY;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTHRITIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BRAZIL; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE CONTROL; DISEASE PREDISPOSITION; ENDOPHTHALMITIS; FEMALE; FEVER; FUNGEMIA; FUSARIOSIS; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; HYPERGLYCEMIA; INFANT; INVASIVE FUSARIOSIS; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MYCOSIS; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; NEWBORN; NONMYELOABLATIVE CONDITIONING; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SINUSITIS; SKIN DEFECT; SMOKING; SMOKING CESSATION; VERY ELDERLY; CLINICAL TRIAL; COMPLICATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; MULTICENTER STUDY; PRESCHOOL CHILD; REMISSION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTILYMPHOCYTE SERUM; BRAZIL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FUSARIOSIS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROSPECTIVE STUDIES; REMISSION INDUCTION; RISK FACTORS; SMOKING; TRANSPLANT RECIPIENTS; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 84936106322     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu947     Document Type: Article

References (40)

1. Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother 2011; 66 (suppl 1):i5-14.
2. Lewis RE, Cahyame-Zuniga L, Leventakos K, et al. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: A 20-year autopsy study. Mycoses 2013; 56:638-45.
3. Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis 2005; 41:521-6.
4. Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50:1091-100.
5. Pagano L, Caira M, Nosari A, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007; 45:1161-70.
6. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 1997; 90:999-1008.
7. Nucci M, Marr KA, Queiroz-Telles F, et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 2004; 38:1237-42.
8. Nucci M, Anaissie EJ, Queiroz-Telles F, et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003; 98:315-9.
9. Li L, Wang J, Zhang W, Yang J, Chen L, Lv S. Risk factors for invasive mold infections following allogeneic hematopoietic stem cell transplantation: A single center study of 190 recipients. Scand J Infect Dis 2012; 44:100-7.
10. Garcia-Vidal C, Upton A, Kirby KA, Marr KA. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis 2008; 47:1041-50.
11. Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007; 20:695-704.
12. Nucci M, Garnica M, Gloria AB, et al. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil. Clin Microbiol Infect 2013; 19:745-51.
13. De Pauw B,Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46:1813-21.
14. Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91:1068-75.
15. Hajjeh RA, Conn LA, Stephens DS, et al. Cryptococcosis: populationbased multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis 1999; 179:449-54.
16. dos SantosWA, da Silva BM, Passos ED, Zandonade E, Falqueto A. Association between smoking and paracoccidioidomycosis: A case-control study in the State of Espirito Santo, Brazil [in Portugese]. Cad Saude Publica 2003; 19:245-53.
17. Leake JA, Mosley DG, England B, et al. Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997. J Infect Dis 2000; 181:1435-40.
18. CairaM, Candoni A, Busca A, et al. Pre-hospital risk factors for invasive fungal diseases in newly diagnosed acute myeloid leukemia: final results from the SEIFEM 2010-a prospective registry [abstract O649]. In: Program and Abstracts of the 23th European Congress of Clinical Microbiology and Infectious Diseases, Berlin, Germany, 2013.
19. Nucci M, Varon AG, Garnica M, et al. Increased incidence of invasive fusariosis with cutaneous portal of entry, Brazil. Emerg Infect Dis 2013; 19:1567-72.
20. Scheel CM, Hurst SF, Barreiros G, Akiti T, Nucci M, Balajee SA. Molecular analyses of Fusarium isolates recovered from a cluster of invasive mold infections in a Brazilian hospital. BMC Infect Dis 2013; 13:49.
21. Domagala-Kulawik J. Effects of cigarette smoke on the lung and systemic immunity. J Physiol Pharmacol 2008; 59(suppl 6):19-34.
22. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010; 34:J258-65.
23. Schuck S, Weinhold A, Luu VT, Baldwin IT. Isolating fungal pathogens from a dynamic disease outbreak in a native plant population to establish plant-pathogen bioassays for the ecological model plant Nicotiana attenuata. PLoS One 2014; 9:e102915.
24. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100:4358-66.
25. De La Rosa GR, Champlin RE, Kontoyiannis DP. Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipients. Transpl Infect Dis 2002; 4:3-9.
26. Pirsch JD, Maki DG. Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Increased susceptibility to fungal infections. Ann Intern Med 1986; 104:619-31.
27. Turina M, Fry DE, Polk HC Jr. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 2005; 33:1624-33.
28. Shoham S, Han G, Granek T,Walsh T, Magee MF. Association between blood glucose levels and development of candidemia in hospitalized patients. Endocr Pract 2009; 15:111-5.
29. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 2012; 54(suppl 1):S23-34.
30. Matias CN, Lima V, Teixeira HM, Souto FR, Magalhaes V. Hyperglycemia increases the complicated infection and mortality rates during induction therapy in adult acute leukemia patients. Rev Bras Hematol Hemoter 2013; 35:39-43.
31. Weiser MA, Cabanillas ME, Konopleva M, et al. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexatecytarabine regimen. Cancer 2004; 100:1179-85.
32. Varon AG, Nouer SA, Barreiros G, et al. Superficial skin lesions positive for Fusarium are associated with subsequent development of invasive fusariosis. J Infect 2014; 68:85-9.
33. Kojima R, Kami M, Nannya Y, et al. Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reducedintensity regimen compared with transplantation with a conventional regimen. Biol Blood Marrow Transplant 2004; 10:645-52.
34. Safdar A, Rodriguez GH, Mihu CN, et al. Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention. Bone Marrow Transplant 2010; 45:339-47.
35. Fukuda T, Boeckh M, Carter RA, et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003; 102: 827-33.
36. Junghanss C, Marr KA. Infectious risks and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the picture? Curr Opin Infect Dis 2002; 15:347-53.
37. Mikulska M, Raiola AM, Bruno B, et al. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients. Bone Marrow Transplant 2009; 44:361-70.
38. Jantunen E, Ruutu P, Niskanen L, et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 1997; 19:801-8.
39. Wald A, Leisenring W, Van Burik JA, Bowden R. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175:1459-66.
40. Offner F, Cordonnier C, Ljungman P, et al. Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis 1998; 26:1098-103.